Table 1.
Characteristics of Study Participants by Birth Gender
| Total N=272 | Male N=213 | Female N=59 | p-valuea | |
|---|---|---|---|---|
| Demographic factors | ||||
| Age in years [Mean (SD)] | 21.5 (2.0) | 21.6 (1.9) | 21.2 (2.2) | 0.19 |
| Race/Ethnicity [N (%)] | ||||
| Non-Hispanic White | 43 (15.8) | 35 (16.4) | 8 (13.6) | 0.38 |
| Non-Hispanic Black/African American/Non-Hispanic, Other | 174 (64.0) | 130 (61.0) | 44 (74.6) | |
| Hispanic | 55 (20.2) | 48 (22.5) | 7 (11.9) | |
| Marital status [N (%)] | ||||
| Single | 209 (77.4) | 170 (80.2) | 39 (67.2) | 0.0034 |
| Living with a steady partner | 43 (15.9) | 33 (15.6) | 10 (17.2) | |
| Married | 10 (3.7) | 3 (1.4) | 7 (12.1) | |
| Separated, divorced, widowed, or other | 8 (3.0) | 6 (2.8) | 2 (3.4) | |
| Sexual orientation [N (%)] | ||||
| Straight | 72 (26.5) | 22 (10.3) | 50 (84.7) | <.0001 |
| Gay/Bisexual/Other | 200 (73.5) | 191 (89.7) | 9 (15.3) | |
| HIV related factors | ||||
| Age at HIV diagnosis [Mean (SD)] | 19.3 (2.3) | 19.5 (2.2) | 18.6 (2.4) | 0.0058 |
| Length of time since HIV diagnosis [Mean (SD)] | 1.9 (1.9) | 1.8 (1.8) | 2.4 (2.2) | 0.035 |
| Self-reported route of HIV infection [N (%)] | ||||
| Perinatal | 1 (0.4) | 1 (0.5) | 0 (0.0) | 0.09 |
| Sex with a man | 241 (88.6) | 189 (88.7) | 52 (88.1) | |
| Sex with a woman | 11 (4.0) | 11 (5.2) | 0 (0.0) | |
| Other/Don't know | 19 (7.0) | 12 (5.6) | 7 (11.9) | |
| CD4+ T cell count (cells/mm3) [Mean (SD)] | 515.5 (252.1) | 500.2 (240.0) | 570.4 (286.9) | 0.10 |
| CD4+ T cell count (cells/mm3) [N (%)] | ||||
| < 350 | 70 (25.8) | 56 (26.4) | 14 (23.7) | 0.74 |
| ≥ 350 | 201 (74.2) | 156 (73.6) | 45 (76.3) | |
| Viral load (copies/mL) [Mean (SD)] | 74528.6 (385987.7) | 89689.1 (435026.3) | 20053.5 (35044.8) | 0.32 |
| Viral load (copies/mL) [N (%)] | ||||
| < 400 | 101 (37.3) | 80 (37.7) | 21 (35.6) | 0.88 |
| ≥ 400 | 170 (62.7) | 132 (62.3) | 38 (64.4) | |
| Viral load (copies/mL) [N (%)] | ||||
| Detectable | 208 (76.8) | 164 (77.4) | 44 (74.6) | 0.73 |
| Non-detectable | 63 (23.2) | 48 (22.6) | 15 (25.4) | |
| HPV Vaccination Status [N (%)] | ||||
| Ever received HPV vaccine | 101 (37.1) | 71 (33.3) | 30 (50.8) | 0.015 |
| Completed one dose only | 34 (12.5) | 25 (11.7) | 9 (15.3) | 0.51 |
| Completed two doses only | 32 (11.8) | 23 (10.8) | 9 (15.3) | 0.36 |
| Completed three doses or more | 35 (12.9) | 23 (10.8) | 12 (20.3) | 0.076 |
a
P-value is derived from a two-sample t-test or Kruskal-Wallis test for continuous variables, and a Fisher's exact test with Monte Carlo estimations for categorical variables, comparing genders.